| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |